Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Puma Biotechnology (NQ: PBYI )

9.615 USD -0.005 (-0.05%)
Streaming Delayed Price Updated: 11:48 AM EDT, Sep 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 144,973
Open 9.620
Bid (Size) 9.600 (2)
Ask (Size) 9.620 (2)
Prev. Close 9.620
Today's Range 9.550 - 9.800
52wk Range 5.500 - 15.00
Shares Outstanding 37,811,611
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Knight Therapeutics Announces Filling of Supplement to a New Drug Submission for NERLYNX® (neratinib) to Treat HER2-Positive Metastatic Breast Cancer
From GlobeNewswire News Releases
Puma Biotechnology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Puma Biotechnology CEO Alan Auerbach will provide a company overview at the virtual H.C. Wainwright Global Conference on September 15, 2020. 
From Business Wire News Releases

Performance

YTD
+14.06%
+14.06%
1 Month
-7.99%
-7.99%
3 Month
-10.22%
-10.22%
6 Month
+4.97%
+4.97%
1 Year
-20.04%
-20.04%

More News

Read More
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Puma Biotechnology Announces Publication of Interim Results of Phase II CONTROL Trial in Annals of Oncology
From Business Wire News Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Puma Biotechnology Reports Second Quarter 2020 Financial Results
From Business Wire News Releases
Interesting PBYI Put And Call Options For November 20th
Tags Stocks
From Market News Video
Puma Biotechnology Announces Publication of Results from Phase II SUMMIT Trial Evaluating Neratinib in HER2-Mutant, Metastatic Cervical Cancers
From Business Wire News Releases
Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results
From Business Wire News Releases
7 Stocks Moving In Wednesday's After-Hours Session
Tags CLIR Benzinga SNPS
From Benzinga
Acentrus Specialty Partners with Puma Biotechnology to Bring Nerlynx® (neratinib) to Health Systems and Hospitals in the Acentrus Network
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.